Jakavi 5 mg/ml, Lösung zum Einnehmen
7680697220016
CH-69722
Lösung
Associated product:
JAKAVI 5 mg/ml sol 5 mg 60 ml
1 / 3
google
Article details
- Package size
- 60
- Selling units
- 60
- Measure
- ml
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ruxolitinibum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
ruxolitinibi phosphas
|
- | Substance | WIZUS |
|
propylenglycolum
|
150.0 MG | Substance | HBESI |
|
E 218
|
1.2 MG | Substance | HBESI |
|
propylis parahydroxybenzoas
|
0.4 MG | Substance | HBESI |
|
sucralosum
|
- | Substance | HNIDK |
|
acidum citricum
|
- | Substance | HNIDK |
|
aromatica
|
- | Substance | AROMA |
|
aqua purificata
|
- | Substance | HNIDK |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69722
- Drug name
- Jakavi, Lösung zum Einnehmen
- Galenic form
- LSOR
- ATC Code
- L01EJ01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 27/03/2025
- Authorization expiration date
- 26/03/2030
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- JAKAVI 5 mg/ml sol 5 mg 60 ml
- Description (DE)
- JAKAVI 5 mg/ml Lös 5 mg 60 ml
- Market launch
- 15/06/2025
- Narcotic (BTM)
- No